High Energy Physics - Phenomenology
[Submitted on 18 Jul 2011]
Title:Diffraction at HERA
View PDFAbstract:Between 1992 and 2007, the HERA accelerator provided $ep$ collisions at center of mass energies beyond $300 \ {\rm GeV}$ at the interaction points of the H1 and ZEUS experiments. Interesting results to emerge relate to the newly accessed field of perturbative strong interaction physics at low Bjorken-$x$, where parton densities become extremely large. Questions arise as to how and where non-linear dynamics tame the parton density growth and challenging features such as geometric scaling are observed. Central to this low $x$ physics landscape is a high rate of diffractive processes, in which a colorless exchange takes place and the proton remains intact. A review is given for main results obtained by H1 and ZEUS experiments in this field.
References & Citations
Bibliographic and Citation Tools
Bibliographic Explorer (What is the Explorer?)
Connected Papers (What is Connected Papers?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)
Code, Data and Media Associated with this Article
alphaXiv (What is alphaXiv?)
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Hugging Face (What is Huggingface?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)
Demos
Recommenders and Search Tools
Influence Flower (What are Influence Flowers?)
CORE Recommender (What is CORE?)
IArxiv Recommender
(What is IArxiv?)
arXivLabs: experimental projects with community collaborators
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.